Weight loss, now in a daily pill
The same sustainable weight loss programme you trust; with clinically proven medication, UK clinicians, and longevity experts. Soon available as a simple oral treatment, no injections required.
Explore oral weight loss medication
Oral weight loss treatment is
coming to the UK very soon.
Injection-free, powerful results.
average body weight loss in clinical trials1
Be the first to access itBe first in line
Waitlist members get priority access at launch.
Join the Waitlist1. OASIS 4: Wharton et al., New England Journal of Medicine (2025)
2. STEP UP: Wharton S, et al. Once-weekly semaglutide 7.2 mg in adults with obesity: a randomised, controlled, phase 3b trial. The Lancet Diabetes & Endocrinology. (2025); SURMOUNT-1: Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. (2022)